BSX vs MAC · P/E 20, rev $16.75B vs rev $918.2M
Boston Scientific Corp (BSX) versus Macerich Company (MAC) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Macerich Company (MAC) is a reit - retail company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported MAC revenue for 2024-12-31 was $918.2M. Net income was -$197.7M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. MAC currently screens at market cap $4.41B.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. MAC currently screens at market cap $4.41B.
Not investment advice. Open the BSX and MAC stock pages for the full models.
Not investment advice.